1.Nosocomial Infections in 36120 Inpatients
Yiping SHEN ; Chenrong MI ; Peifen QIAN
Chinese Journal of Nosocomiology 2009;0(14):-
OBJECTIVE To investigate the status of nosocomia infection and provide scientific reference for nosocomial infection control.METHODS Retrospective analysis based on the nosocomial infection materials of January,April,July,October,from 2006 to 2007 were conducted.RESULTS Both the infection incidence and the infection ratio were 4.66% and 5.97%,The main infection sites were lower respiratory tract,urinary tract and gastrointestinal tract.The risk factors were central venous catheters,urine catheters and mechanical ventilation.The nosocomial infection cases were compared with non-nosocomial infection control cases in age,number of days in hospital,death rate and medical treatment fee.There were significant difference between them.CONCLUSIONS It is an efficiency step in preventing infection from central venous catheters,urine cathters and mechanical ventilation,protecting sensitized hosts and developing the prospective analysis of nosocomial infection monitoring.
2.Dynamic Contrast-enhanced MR Angiography of the Renal Arteries
Mingxia FAN ; Kangrong ZHOU ; Peifen WANG ; Jizhang SHEN
Journal of Practical Radiology 2001;0(07):-
Objective To evaluate the diagnostic value of dynamic contrast-enhanced MR angiography(DCE MRA)of the renal arteries.Methods 18 patients suspected with renal arterial diseases underwent DCE MR Angiography examinations.After 20 ml(0.15~0.20 mmol/kg)Gd-DTPA being injected quickly via cubital vein,a scaning and data acquisition with coronal three-demensional fast spoiled gradient(FSPGR)sequence was performed in a breath-hold time,the source images were introduced into work station for post processing,including maximum intensity projection(MIP)and multiplanner reconstruction(MPR),finally 3D DCE MRA images were obtained.Results A comparative study on renal artery stenosis and its degree between DCE MR angiography and DSA was done in 25 arteial segments of 12 cases.In 12 normal renal arteries shown by DSA,DCE MRA found 11 normal and one mild stenosis;Four moderate and one severe stenosis was shown by DCE MRA in five renal arteries with moderate stenosis identified by DSA;DCE MRA found five severe stenosis and three occlusion of renal anteries,which had accordance with DSA findings.Conclusion Dynamic contrast-enhanced MR angiography can accurately assess renal arterial diseases,the accuracy was especially higher in patients with severe arterial stenosis and occlusion.
3.PRODUCTION AND CHARACTERIZATION OF A MONOCLONAL ANTI-HUMAN LEUCOCYTE ANTIBODY(1C34-5)
Yan BAI ; Meiqin SHI ; Peifen SHEN ; Dehui CHEN
Medical Journal of Chinese People's Liberation Army 1983;0(05):-
A monoclonal antibody 1C34-5 raised against human peripheral mononuclear cells was produced. This antibody, a monoclonal IgG1. showed positive reaction with about 90% of T and B lymphocytes, monocytes. granulocytes and bone marrow cells, but negative reaction with red blood cells and platelets by indirect immunoflurorescent technique. 1C34-5 also reacted with leucocytic cell lines except a non-T non-B lymphoid line Reh but not with erythroid line K562, HeLa cells and fibroblast cells so far tested.This antibody was also assayed histologically by an indirect immunoperoxidase technique against a variety of human normal tissue frozen sections. It was found that 1C34-5 bound to all lymphoid tissues including lymph nodes, tonsil, thymus. Peyer's patches and leucocytes scattered in other tissues, but not to all non-hematopoietic tissues as well as erythropoietic foci in fetal liver. Thus. 1C34-5 appears to recognize a human leucocyte antigen specifically.
4.Orthotopic liver transplantation with no veno-venous bypass.
Shusen ZHENG ; Dongsheng HUANG ; Jian WU ; Weilin WANG ; Yan SHEN ; Min ZHANG ; Qingyun SHEN ; Anwei LU ; Peifen FU ; Xiao XU
Chinese Journal of Surgery 2002;40(5):326-328
OBJECTIVETo assess the feasibility and outcome of orthotopic liver transplantation (OLT) with no veno-venous bypass (VVB) in adult patients.
METHODSBetween 1999 and June 2001, 43 adult patients were subjected to orthotopic liver transplantations with veno-venous bypass (28), or no veno-venous bypass (15).
RESULTSThere was no significant difference in mean serum creatinine on day 3 and gas discharge time in patients with veno-venous bypass or not. With no veno-venous bypass, the average operative time was 5.6 +/- 1.4 h, median amount of blood loss during operation was 4 200 +/- 850 ml, median amount of blood transfused intraoperatively was 4 800 +/- 920 ml, and median intensive care unit stay was 6.3 days. All these were lower or shorter than those of the patients with veno-venous bypass.
CONCLUSIONSOrthotopic liver transplantation with no veno-venous bypass is safe and can be performed in the majority of adult patients. Liver transplantation with no veno-venous bypass is associated with shorter total operating time, lower blood product usage, and shorter intensive care unit stay compared with standard technique of OLT with routine use of VVB.
Adult ; Creatinine ; blood ; Feasibility Studies ; Female ; Hepatic Veins ; surgery ; Humans ; Liver Diseases ; blood ; surgery ; therapy ; Liver Transplantation ; methods ; Male ; Middle Aged ; Outcome Assessment (Health Care) ; Vascular Surgical Procedures
5.Mechanism of transforming growth factor- β1 induce renal fibrosis based on transcriptome sequencing analysis.
Huanan LI ; Peifen LI ; Shanyi LI ; Xueying ZHANG ; Xinru DONG ; Ming YANG ; Weigan SHEN
Journal of Zhejiang University. Medical sciences 2023;52(5):594-604
OBJECTIVES:
To explore the mechanism of transforming growth factor-β1 (TGF-β1) induce renal fibrosis.
METHODS:
Renal fibroblast NRK-49F cells treated with and without TGF-β1 were subjected to RNA-seq analysis. DESeq2 was used for analysis. Differentially expressed genes were screened with the criteria of false discovery rate<0.05 and l o g 2 F C >1. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed for differentially expressed genes. Genes encoding transcription factors were further screened for differential expression genes. Then, the expression of these genes during renal fibrosis was verified using unilateral ureteral obstruction (UUO)-induced mouse renal fibrosis model and a public gene expression dataset (GSE104954).
RESULTS:
After TGF-β1 treatment for 6, 12 and 24 h, 552, 1209 and 1028 differentially expressed genes were identified, respectively. GO analysis indicated that these genes were significantly enriched in development, cell death, and cell migration. KEGG pathway analysis showed that in the early stage of TGF-β1 induction (TGF-β1 treatment for 6 h), the changes in Hippo, TGF-β and Wnt signaling pathways were observed, while in the late stage of TGF-β1 induction (TGF-β1 treatment for 24 h), the changes of extracellular matrix-receptor interaction, focal adhesion and adherens junction were mainly enriched. Among the 291 up-regulated differentially expressed genes treated with TGF-β1 for 6 h, 13 genes (Snai1, Irf8, Bhlhe40, Junb, Arid5a, Vdr, Lef1, Ahr, Foxo1, Myc, Tcf7, Foxc2, Glis1) encoded transcription factors. Validation in a cell model showed that TGF-β1 induced expression of 9 transcription factors (encoded by Snai1, Irf8, Bhlhe40, Junb, Arid5a, Vdr, Lef1, Myc, Tcf7), while the expression levels of the other 4 genes did not significantly change after TGF-β1 treatment. Validation results in UUO-induced mouse renal fibrosis model showed that Snai1, Irf8, Bhlhe40, Junb, Arid5a, Myc and Tcf7 were up-regulated after UUO, Vdr was down-regulated and there was no significant change in Lef1. Validation based on the GSE104954 dataset showed that IRF8 was significantly overexpressed in the renal tubulointerstitium of patients with diabetic nephropathy or IgA nephropathy, MYC was highly expressed in diabetic nephropathy, and the expressions of the other 7 genes were not significantly different compared with the control group.
CONCLUSIONS
TGF-β1 induces differentially expressed genes in renal fibroblasts, among which Irf8 and Myc were identified as potential targets of chronic kidney disease and renal fibrosis.
Mice
;
Animals
;
Humans
;
Transforming Growth Factor beta1/metabolism*
;
Diabetic Nephropathies/pathology*
;
Transcriptome
;
Signal Transduction
;
Kidney
;
Ureteral Obstruction/pathology*
;
Fibrosis
;
Interferon Regulatory Factors
;
Transforming Growth Factor beta/metabolism*
;
DNA-Binding Proteins/metabolism*
;
Transcription Factors/metabolism*